CoFit
The effect of exercise on the risk of recurrence in patients with colorectal carcinoma – one of the registered practitioner’s „FIT-Projects“
Project partner
iOMEDICO AG, Freiburg im Breisgau
Project description
Numerous studies prove the positive effect of exercise on the quality of life and the prognosis of patients with cancer diseases.
CoFit prospectively evaluates the effect of exercise on the rate of recurrence of a non-selected patient population in real life. The patients are asked about kind and extent of exercise by means of a validated questionnaire twice a year. The observation period for each patient is five years or until occurrence of a recurrence.
The simultaneous capture of health data during the entire course of the disease allows the linking of data from questionnaires with medical data such as occurrence of recurrence. The five-year follow-up observation period for CoFit is complete. The final evaluation will answer many questions on the effects of exercise. The publication is supported by the Leonardis Foundation.
Project start: 4th quarter 2006.
MaFit
The effect of exercise on the risk of recurrence in patients with breast cancer – one of the registered practitioner‘s „FIT-Projects“
Project partner
iOMEDICO AG, Freiburg im Breisgau
Project description
Several studies prove the positive effect of exercise on the quality of life and the prognosis of patients with cancer diseases.
MaFit prospectively evaluates the effect of exercise on the rate of recurrence of a non-selected patient population in real life. The patients are asked about kind and extent of exercise by means of a validated questionnaire twice a year. The observation period for each patient is five years or until occurrence of a recurrence.
The simultaneous capture of health data during the entire course of the disease allows the linking of data from questionnaires with medical data such as occurrence of recurrence. The five-year follow-up observation period for MaFit is complete.
The final evaluation of MaFit is planned for 2016 and will answer many questions on the effects of exercise. The publication is supported by the Leonardis Foundation.
Project start: 4th quarter 2007.
CiPNP-Galileo I
Assessment of the effect of a specific muscle vibration training with Galileo® in patients with breast or gastrointestinal tumours and chemotherapy-induced polyneuropathy (CiPNP)
Project partner
Klinik für Tumorbiologie, Freiburg;
Forschungs GbR, Freiburg;
Institut für Sport und Sportwissenschaften der Albert-Ludwigs-Universität Freiburg
Project description
Numerous chemotherapeutics can cause serious nerve damage in patients, above all chemotherapy induced polyneuropathy (CiPNP). Mostly the affected complain about uncomfortable paraesthesia especially in their feet and hands, unsteadiness when walking, standing or gripping or increased sensitivity to cold or inclination to muscle cramps. In rare cases signs of paralysis can occur. Therefore the occurrence of CiPNP can lead to a significantly reduced quality of life. To date no long-lasting effective therapy exists. Based on extensive preliminary assessments we now hope to show that a targeted whole body vibration training with Galileo® will lead to a repair of the damaged nerve fibres and thus to an improvement of the clinical ailments as well as the quality of life within the CiPNP-Galileo I study
Project start: 2nd quarter 2014.
Planned Projects
CiPNP-Galileo II
Clinical Study to evaluate the effects of whole body vibration training with Galileo® on quality of life and the development of chemotherapy induced polyneuropathy (CiPNP) in patients with breast or gastrointestinal tumours who receive an anti-tumour therapy with neurotoxic compounds.
Project partner
Praxis für Interdisziplinäre Onkologie und Hämatologie in Freiburg;
Forschungs GbR, Freiburg;
Institut für Sport und Sportwissenschaften der Albert-Ludwigs-Universität Freiburg
Project description
The CiPNP-Galileo 2 study is based on the findings of CiPNP-Galileo 1. The follow-up study will evaluate whether the whole body vibration training with Galileo® can counteract the damage of the nervous system in patients being treated with neurotoxic chemotherapeutics and thus improve the tolerability of the therapy as well as quality of life
Project start: 1st quarter 2016
ViBBRAa II
Vibration und balance training in breast cancer patients during and after adjuvant radiotherapy.
Project partner
Forschungs GbR, Freiburg i.Br.;
Institut für Sport und Sportwissenschaften der Albert-Ludwigs-Universität Freiburg
Project description
The ViBBRa 2 study is based on the finding of the ViBBRa 1 study (see below). The positive effects of the special dumbbell vibration training in patients after breast cancer under radiation therapy, such as e.g. an improvement of the mobility of the shoulder, the preservation of the depth sensitivity as well as reduction of treatment induced tiredness should also be proven in this clinical follow-up study in a larger patient population.
Project start: 1st quartal 2016
ViBBRAa I
Vibration und balance training in breast cancer patients during and after adjuvant radiotherapy.
Project partner
Zentrale Einrichtung Bewegungsmedizin und Sport, Freiburg;
Institut für Sport und Sportwissenschaften der Albert-Ludwigs-Universität Freiburg;
Medizin I Hämatologie, Onkologie und Stammzelltransplantation des Universitätsklinikums Freiburg.
Project description
Patients after breast cancer suffer from a number of side effects following their treatment (e.g. operations and local radiation therapy). These can significantly impair quality of life. In particular, these include restrictions in mobility of the shoulder, disturbance of sensitivity in feet and hands, lymph oedema of the arms, reduction of fitness, tiredness and fatigue. Many of these symptoms could be reduced in preliminary evaluations by means of a target dumbbell vibration training during radiation treatment. The goal of this pilot study was therefore to assess the feasibility and efficacy of a special dumbbell vibration training in patients after breast cancer under radiation treatment.
Donation Account:
Volksbank Freiburg
IBAN: DE91 6809 0000 0038 2290 01
BIC: GENODE61FR1